May 14, 2008 - A randomized controlled trial conducted by Brigham and Women's Hospital in affiliation with Harvard ...
Many formerly invasive diagnostic and interventional cardiology procedures have migrated to less invasive or percutaneous options. The subsequent rise in cath lab procedures has increased the need for alternatives to manual compression that promote hemostasis at the access site, allowing for quicker patient ambulation and throughput.
Boston Scientific has expanded its portfolio with COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter defibrillator (ICD), new platforms to treat heart failure and sudden cardiac death.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 13, 2008 - Edwards Lifesciences Corp. launched a next-generation transfemoral delivery system for the Edwards SAPIEN ...
Abbott Vascular’s HI-TORQUE WHISPER guidewire is designed to offer a higher level of support to facilitate device ...
The Edwards Lifesciences unveiled a new software upgrade that allows greater flexibility to trend and analyze the ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 13, 2008 – The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, said to be the world’s first high-definition CT ...
The FDA cleared for marketing a new automated version of diaDexus’ proprietary PLAC Test, an automated immunoassay designed to run on common existing laboratory equipment, including clinical chemistry analyzers from Hitachi, Roche/Hitachi and Olympus, expanding the number of clinical labs and physician offices that are able to offer the PLAC Test.
TomTec Imaging Systems recently announced that its new CardioArena, the network and imaging solution for cardiology ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 13, 2008 - Medtronic received FDA premarket approval (PMA) for the first wave of cardiac rhythm disease management ...
Northeast Monitoring received clearance from the FDA to sell its DR200 Series devices with its automatic atrial ...
Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 13, 2008 – The FDA approved changes to the U.S. product label for DEFINITY Vial For (Perflutren Lipid Microsphere) ...
Boston Scientific’s IQ Guidewire is designed to provide the torque response, side branch access support and device ...
The Promote RF CRT-D and Current RF ICD feature InvisiLink radiofrequency (RF) telemetry for reportedly secure, wireless communication between the implanted device and the programmer, have extended their reach with the new Durata lead.